Additionally, preclinical research suggests potential applications in treating chronic conditions, including inflammatory bowel disease and fibrotic disorders
No office visits, no scheduling around a provider's availability
Body composition data from the SURMOUNT-1 DXA substudy showed approximately 75% of weight lost came from fat mass and 25% from lean mass
Drug-Food Interactions None Drug-Disease Interactions Optineuron Injection may interact with diseases/conditions, including: Vitamin Lebers disease: B12 preparations should be used cautiously in patients with hereditary optic nerve disorders, as optic nerve damage may worsen
Research measuring inflammatory markers shows the combination lowers pro-inflammatory cytokines (IL-6, TNF-alpha) by 6080%, versus 3040% for either peptide alone translating to less pain, less swelling, and a faster return to function without sacrificing healing quality